Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy

Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy

Inflammation plays a key role in cardiovascular disease by contributing to atherothrombosis. The PLATelet inhibition and patient Outcomes (PLATO) study (NCT00391872) compared ticagrelor to clopidogrel in patients with acute coronary syndromes and demonstrated fewer cardiovascular events with ticagre...

Full description

Bibliographic Details
Main Authors: Thomas A. Nelson, William A.E. Parker, Tatevik Ghukasyan Lakic, Johan Westerbergh, Stefan K. James, Agneta Siegbahn, Richard C. Becker, Anders Himmelmann, Lars Wallentin, Robert F. Storey
Format: Article
Language:English
Published: Taylor & Francis Group 2022-04-01
Series:Platelets
Subjects:
clopidogrel
ticagrelor
microrna
acute coronary syndromes
leukocyte
inflammation
Online Access:http://dx.doi.org/10.1080/09537104.2021.1934667

Internet

http://dx.doi.org/10.1080/09537104.2021.1934667

Similar Items